Kite Pharma - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Kite Pharma M&A Summary

Kite Pharma has acquired 3 companies of its own, including 1 in the last 5 years. It has also divested 1 asset.

Kite Pharma’s largest acquisition to date was in 2017, when it acquired Cell Design Labs for $567M. Kite Pharma has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include life science (100%).

Kite Pharma Ownership

Who owns Kite Pharma?

Kite Pharma is owned by Gilead Sciences. It was acquired on August 28, 2017.

Was Kite Pharma formerly PE-backed?

Yes. Kite Pharma was formerly owned by 1 private investor.

Kite Pharma Business Overview

Where is Kite Pharma headquartered?

Kite Pharma is headquartered in Santa Monica, California.

What is Kite Pharma’s revenue?

Kite Pharma disclosed revenue of 22M USD for 2016 and 17M USD for 2015.

How many employees does Kite Pharma have?

Kite Pharma has 184 employees.

What sector is Kite Pharma in?

Kite Pharma is a life science company.

When was Kite Pharma founded?

Kite Pharma was founded in 2009.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2
  • M&A Advisors 1

Kite Pharma, Inc.

2225 Colorado Avenue,
Santa Monica, California 90404
United States,
(310) 824-9999
www.kitepharma.com

Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. Kite Pharma was formed in 2009 and is based in Santa Monica, California.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 2 - 1 - - - 3
vol $590M $590M
Sell (0.2/yr) # - 1 - - - - 1
  4

Most Recent M&A

Company Date Value Type
Tmunity Therapeutics, Inc. 2022-12-20 - Divestiture
Philadelphia, Pennsylvania · www.tmunity.com
Kite Pharma - Neoantigen TCR Cell Therapy R&D Platform & Manufacturing Facility 2021-07-19 - Divestiture
Gaithersburg, Maryland
Cell Design Labs, Inc. 2017-12-07 567M USD Add-on Acquisition
Emeryville, California · www.celldesignlabs.com
T-Cell Factory B.V. 2015-03-17 23M EUR Add-on Acquisition
, Netherlands
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 3 (100%) 590M (100%) 1 (100%) -
Total 3 $590M 1 -

By Geo

State/Country Buy Value Sell Value
United States 2 567M 1 -
  Pennsylvania 1 - - -
  California 1 567M - -
  Maryland - - 1 -
Netherlands 1 23M - -
Domestic 2 (67%) 567M (96%) 1 (100%) -
Cross-border 1 (33%) 23M (4%) - -
Total 3 $590M 1 -

Top M&A Advisors

Financial Deals
Cowen
2

Deal Values

buy # Total
$100M to $1B 1 $567M
< $100M 1 $23M
TOTAL $590M
Largest Cell Design Labs, Inc.
$567M (2017-12-07)

M&A Connections

Deals
Acquired from
Strategic(s)
33%
1 (33%)
Divested to
Strategic(s)
100%
1 (100%)

Try Mergr Free — See This and 215,368+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 209K M&A Transactions
  • 211K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Kite Pharma

Life Science Companies